Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2018-05-20 11:57 CEST (UTC+2h)
 
heritage
Junior

India,
2018-05-05 06:25

Posting: # 18755
Views: 494
 

 Bioequivalence of IR vs MR tablet [Design Issues]

One drug has been approved as IR tablet given 100 mg bid (total dose 200 mg). We want to make one ER formulation of 230 mg which can be given once daily. I need help in following issues

1. What should be the design?
2. Which PK parameter I should be looking at?
3. Should I do fasting or fed study?
4. Should I targeting BE in Cmax or AUC?

Please give me some reading material or link to any post wherein this had been already discussed

Thanks in advance


Edit: Category changed; see also this post #1. [Helmut]
bebac_fan
Junior

US,
2018-05-05 17:08

@ heritage
Posting: # 18756
Views: 400
 

 Consider 505(b)(2) Pathway

I think this would need to go through a NDA/505(b)(2) pathway rather than an ANDA.

In this case, comparative efficacy, rather than BE, will be considered pivotal.
Obinoscopy
Junior

Nigeria,
2018-05-15 19:04

@ bebac_fan
Posting: # 18764
Views: 103
 

 Pathway for Softgel vs Tablet Comparison

Dear bebac_fan,

» I think this would need to go through a NDA/505(b)(2) pathway rather than an ANDA.
»

I share the same view with you on this.

However I have a case where a BE study was conducted comparing Metronidazole tablet (Reference) with Metronidazole soft gel (test). Both were IR. Is this acceptable?

Regards,

Scopy
jag009
Hero

NJ,
2018-05-18 16:33

@ Obinoscopy
Posting: # 18786
Views: 54
 

 Pathway for Softgel vs Tablet Comparison

Hi,

» However I have a case where a BE study was conducted comparing Metronidazole tablet (Reference) with Metronidazole soft gel (test). Both were IR. Is this acceptable?

Have you read this guidance? FDA

John
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum | Admin contact
18,268 posts in 3,882 threads, 1,162 registered users;
14 users online (0 registered, 14 guests).

Power. That which statisticians are always calculating
but never have.    Stephen Senn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed